交易 Compass Pathways PLC - ADR - CMPS 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.11
• 长仓隔夜仓息调整: -0.02151%
• 短仓隔夜仓息调整: -0.00071%
• 隔夜调整仓息时间: 21:00 (UTC)
• 货币: USD
• 最低成交量: 10
• 保证金: 5.00%
• 证券交易所: United States of America
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: 12.47
• 开仓: 12.94
• 1 年变化: 181.3%
• 日区间: 12.36 - 12.94

交易 Compass Pathways PLC - ADR - CMPS 差价合约

Compass Pathways PLC - ADR (NASDAQ: CMPS) is a UK-based mental health biotech developing psilocybin-based therapies for treatment-resistant depression. Its lead candidate, COMP360, is in Phase 3 trials and aims to become the first FDA-approved psychedelic-assisted therapy. Compass is a high-risk, high-reward biotech tied to the future of mental healthcare and psychedelic medicine.